[
    "{\"step_by_step_thinking\": \"Based on the provided documents, there is evidence of at least one anti-amyloid antibody that has been approved as a drug for Alzheimer's disease treatment. Document [0] mentions that aducanumab, a humanized recombinant monoclonal antibody to amyloid \u00df, was the first potential disease-modifying therapy approved by the US Food and Drug Administration (FDA) to treat Alzheimer's disease and mild cognitive impairment. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]